-
CD1d-specific single-domain antibodies for unconventional immunomodulation
Lameris, R., 2024, 249 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
-
Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions
Lameris, R., Shahine, A., Veth, M., Westerman, B., Godfrey, D. I., Hulsik, D. L., Brouwer, P., Rossjohn, J., de Gruijl, T. D. & van der Vliet, H. J., 1 Dec 2023, In: Journal for Immunotherapy of Cancer. 11, 12, e007631.Research output: Contribution to journal › Article › Academic › peer-review
-
A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
Lameris, R., Ruben, J. M., Iglesias-Guimarais, V., de Jong, M., Veth, M., van de Bovenkamp, F. S., de Weerdt, I., Kater, A. P., Zweegman, S., Horbach, S., Riedl, T., Winograd, B., Roovers, R. C., Adang, A. E. P., de Gruijl, T. D., Parren, P. W. H. I. & van der Vliet, H. J., 21 Mar 2023, In: Cell Reports Medicine. 4, 3, p. 100961 100961.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
